Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8228966 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 7 Pages |
Abstract
Concurrent EGFR-TKIs with individualized RT shows a favorable safety profile and promising outcome, therefore serving as a therapeutic option for patients with locally advanced or metastatic NSCLC.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jing M.D., Ph.D., Ting-Yi M.D., Ph.D., Ying-Jie M.D., Hong-Qi M.D., Ping M.D., Ji-Dong M.D., Dong-Shu M.D., Liy-Yuan M.D., Yu-Peng M.D., Xuan M.D., Wei-Zhang Ph.D.,